Eating disorders: evaluation and specialist care
Restrictive eating, recurrent bingeing, purging or fear around food can affect both physical and mental health at any body size. An Ondoc clinician can discuss the concern and help plan appropriate medical assessment and specialist referral.
What your visit can cover
- Review eating patterns, restriction, bingeing, compensatory behaviors and physical symptoms
- Identify medical instability and the need for examination, testing or urgent care
- Discuss a coordinated eating-disorder team, psychotherapy and nutritional support
When to be seen in person
Fainting, chest pain, confusion, dehydration, inability to eat or drink, vomiting blood or severe weakness need urgent in-person care. Medical danger can occur at any weight. Call 911 for immediate danger.
About Eating disorders
Anorexia nervosa includes restriction with a significantly low weight and fear of weight gain or related behaviors; atypical anorexia can carry serious risk without a low weight. Bulimia nervosa involves recurrent binge episodes and compensatory behavior such as vomiting. Binge-eating disorder involves recurrent distressing binges without regular compensatory behaviors. ARFID involves restrictive intake related to sensory avoidance, fear of consequences or low interest in food rather than body-image concerns. Treatment is diagnosis-specific and may combine medical monitoring, nutritional rehabilitation and psychotherapy. Family-based treatment is important for many adolescents with anorexia; CBT-based approaches can help bulimia and binge eating. Nutritional rehabilitation and inpatient stabilization require an appropriate specialist team or facility.
Additional medication information
Educational options, not an offer of a prescription from every provider. No dose or ordering instruction is provided.
- Fluoxetine for bulimia nervosa
- Fluoxetine is FDA-approved for bulimia nervosa. Its role differs from treating anorexia or ARFID; it does not replace nutrition and psychotherapy.
- Lisdexamfetamine for binge-eating disorder
- FDA-approved for moderate to severe binge-eating disorder in adults, not for weight loss or anorexia. It is a controlled medicine with important risks; whether it is appropriate is an individual clinical decision.
- Medication limitations
- There is no FDA-approved medication for anorexia nervosa or ARFID. Bupropion is contraindicated in patients with a current or prior diagnosis of bulimia or anorexia because of seizure risk.